By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Polarean Imaging plc

Polarean Imaging plc (POLX.L)

LSE Market Data in GBP, Fundamentals in USD
£1.20
+£0.03
+2.13%
Last Update: 17 Jul 2025, 11:36
£14.48M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
£0.85 - £2.00
52 Week Range

POLX.L Stock Price Chart

Explore Polarean Imaging plc interactive price chart. Choose custom timeframes to analyze POLX.L price movements and trends.

There is nothing to show.

POLX.L Company Profile

Discover essential business fundamentals and corporate details for Polarean Imaging plc (POLX.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

29 Mar 2018

Employees

29.00

CEO

Christopher Richard Von Jako

Description

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.

POLX.L Financial Timeline

Browse a chronological timeline of Polarean Imaging plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 6 May 2026

Upcoming earnings on 2 Sept 2025

Earnings released on 8 May 2025

Earnings released on 4 Sept 2024

EPS came in at -£0.01, while revenue for the quarter reached £885.82K.

Earnings released on 28 Jun 2024

Earnings released on 28 May 2024

Stock split effective on 23 May 2024

Shares were split 293:250, changing the number of shares outstanding and the price per share accordingly.

Earnings released on 15 Sept 2023

EPS came in at -£0.01, while revenue for the quarter reached £56.20K.

Earnings released on 26 May 2023

EPS came in at -£0.01, while revenue for the quarter reached £81.08K.

Earnings released on 31 Mar 2023

EPS came in at -£0.01, while revenue for the quarter reached £57.58K.

Earnings released on 30 Sept 2022

EPS came in at -£0.01, while revenue for the quarter reached £89.90K.

Earnings released on 30 Jun 2022

EPS came in at -£0.01, while revenue for the quarter reached £343.51K.

Earnings released on 18 May 2022

Earnings released on 2 Sept 2021

EPS came in at -£0.02, while revenue for the quarter reached £450.16K.

Earnings released on 4 Jun 2021

EPS came in at -£0.01, while revenue for the quarter reached £512.09K.

Earnings released on 30 Sept 2020

POLX.L Stock Performance

Access detailed POLX.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
POLX.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
POLX.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More